Industry Pulse: The “Connected” Pharmaceutical Supply Chain for Resiliency and Agility

~ 1 min Read

With regulatory intensity, global disruptions and profitability pressures on the rise, demand for a connected pharmaceutical supply chain is at an all-time high. Top priorities for 2021 include visibility across all operations, forecasts based on market realities, end-to-end quality and serialization, supply assurance of core ingredients, reliable and secure distribution of pharmaceuticals, and navigating an increasingly complex logistics and global trade landscape. Join us to learn how to connect an inherently disconnected supply chain and achieve a new level of resiliency and agility.

Gain valuable insights on:

  • Steps to digitally connect upstream, downstream and logistics ecosystem partners for enhanced visibility, process orchestration and aligned decision-making.
  • Successful end-to-end strategies to manage rapid swings in demand and supply, limited transportation availability and new border compliance restrictions.
  • How leaders used artificial intelligence (AI) and real-time data during the pandemic to understand rapidly changing consumer behavior and keep goods flowing despite the unprecedented disruption.


Pawan Joshi Pawan Joshi
Executive Vice President,
Product Management & Strategy

Industry Pulse: The “Connected” Pharmaceutical Supply Chain for Resiliency and Agility
e2open Subscription Center

Subscribe to Receive e2open Updates

Interested in learning more? Stay current with the latest e2open news – from company updates to thought-leadership pieces, and so much more!

Complete this form to subscribe to e2open updates.


Let's Get Started.

Let's Get Started.